[Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].
van Laar
Teus
T
Afd. Neurologie, Universitair Medisch Centrum Groningen, Groningen. t.van.laar@neuro.umcg.nl
Berendse
Henk
H
Bloem
Bas R
BR
Boon
Agnita J W
AJ
van Hilten
Johannes J
JJ
Hovestadt
Ad
A
de Koning-Tijssen
Marina A J
MA
Nijssen
Peter C G
PC
Weber
Wim E J
WE
D018491:Dopamine Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D004452:Echocardiography; D005355:Fibrosis / Q000139:chemically induced* / Q000453:epidemiology; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy; D010479:Pergolide / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors
D018491:Dopamine Agonists; D010479:Pergolide